Art

J-GLOBAL ID：201602210710149650   Reference number：16A0106016

Emergence of Daptomycin-Resistant Staphylococcus aureus during Treatment

治療中のダプトマイシン耐性黄色ブドウ球菌の発生

Author (10)： HAGIYA Hideharu (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  HARUKI Yuto (Dep. of Pharmacy, Tsuyama Chuo Hospital, JPN) ,  UCHIDA Taeko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  WADA Tomoko (Dep. of Pharmacy, Tsuyama Chuo Hospital, JPN) ,  WADA Tomoko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  SHIOTA Sumiko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  ISHIDA Tomoharu (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  OGAWA Hiroko (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  MURASE Tomoko (Dep. of Clinical Lab., Microbiology Div., Tsuyama Chuo Hospital, JPN) ,  OTSUKA Fumio (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 55  Issue： 1  Page： 73-78 (J-STAGE)  Publication year： 2016 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Catheter infection ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0106016&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (1)： Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (4)： Daptomycin ,  Vancomycin ,  Meropenem ,  Linezolid

Reference (33)：

• 1. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47: 2538-2544, 2003.
• 2. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52: e18-e55, 2011.
• 3. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355: 653-665, 2006.
• 4. Sakoulas G, Alder J, Thauvin-Eliopoulos C, et al. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 50: 1581-1585, 2006.
• 5. Suzuki M, Tawada Y, Kato M, et al. Development of a rapid strain differentiation method for methicillin-resistant Staphylococcus aureus isolated in Japan by detecting phage-derived open-reading frames. J Appl Microbiol 101: 938-947, 2006.

Terms in the title (4)： 治療 ,  ダプトマイシン ,  耐性 ,  黄色ブドウ球菌